CIK 0001557746 · Non-accelerated filer<br>Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460571712
- Phone
- 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-02 | Ruffo Frank Chief Financial Officer | Option exercise · Restricted stock units | −8,297 | 16,595 | ||
| 2022-03-02 | Walker Neal President and CEO | Option exercise | +18,254 | 1,372,066 | ||
| 2022-03-02 | Walker Neal President and CEO | Option exercise · Restricted stock units | −18,254 | 36,508 | ||
| 2022-03-01 | Monahan Joseph Chief Scientific Officer | Option exercise | +13,750 | 101,051 | ||
| 2022-03-01 | Monahan Joseph Chief Scientific Officer | Option exercise | +50,000 | 151,051 | ||
| 2022-03-01 | Monahan Joseph Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +153,100 | 153,100 | ||
| 2022-03-01 | Monahan Joseph Chief Scientific Officer | Grant or award · Restricted stock units | +43,700 | 43,700 | ||
| 2022-03-01 | Monahan Joseph Chief Scientific Officer | Option exercise · Restricted stock units | −13,750 | 13,750 | ||
| 2022-03-01 | Monahan Joseph Chief Scientific Officer | Option exercise · Restricted stock units | −50,000 | 150,000 | ||
| 2022-03-01 | Ruffo Frank Chief Financial Officer | Option exercise | +25,750 | 198,109 | ||
| 2022-03-01 | Ruffo Frank Chief Financial Officer | Option exercise | +8,300 | 206,409 | ||
| 2022-03-01 | Ruffo Frank Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +155,200 | 155,200 | ||
| 2022-03-01 | Ruffo Frank Chief Financial Officer | Grant or award · Restricted stock units | +44,300 | 44,300 | ||
| 2022-03-01 | Ruffo Frank Chief Financial Officer | Option exercise · Restricted stock units | −25,750 | 25,750 | ||
| 2022-03-01 | Ruffo Frank Chief Financial Officer | Option exercise · Restricted stock units | −8,300 | 24,900 | ||
| 2022-03-01 | Walker Neal President and CEO | Option exercise | +96,150 | 1,335,537 | ||
| 2022-03-01 | Walker Neal President and CEO | Option exercise | +18,275 | 1,353,812 | ||
| 2022-03-01 | Walker Neal President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +336,100 | 336,100 | ||
| 2022-03-01 | Walker Neal President and CEO | Grant or award · Restricted stock units | +96,000 | 96,000 | ||
| 2022-03-01 | Walker Neal President and CEO | Option exercise · Restricted stock units | −96,150 | 96,150 |
Page 26 of 34 · 680 trades